Acadian Asset Management
CGTX icon

Acadian Asset Management’s Cognition Therapeutics CGTX Stock Holding History

Acadian Asset Management’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-701,940
Closed -$216K – 1844
2025
Q2 		$216K Sell
701,940
-305,646
-30% -$103K ﹤0.01% 1296
2025
Q1 		$422K Buy
1,007,586
+897,353
+814% +$527K ﹤0.01% 1112
2024
Q4 		$76K Sell
110,233
-30,710
-22% -$15.2K ﹤0.01% 1400
2024
Q3 		$64K Buy
+140,943
New +$145K ﹤0.01% 1736
2024
Q2 		– Sell
-12,691
Closed -$23K – 1766
2024
Q1 		$23K Buy
+12,691
New +$26.2K ﹤0.01% 1471

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $626M AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return